Madison Square Garden Sports (MSGS) is under fresh scrutiny after a very public clash with New York City officials over crowd limits and security for the Knicks’ NBA Finals Game 4 watch party.

Despite the public clash with city officials, investors have focused on performance in the background, with the share price at $386.37 and a 49.26% year to date share price return alongside a 102.03% 1 year total shareholder return that points to strong momentum rather than a short term spike.

If this kind of headline risk has you thinking about where else excitement and ownership matter, it could be a good moment to scan 19 top founder-led companies.

With Madison Square Garden Sports delivering a 49.26% year to date share price return and a 102.03% 1 year total shareholder return, the key question now is whether MSGS is still undervalued or if the market is already pricing in future growth.

Most Popular Narrative: 10.8% Overvalued

At a last close of $386.37 against a narrative fair value of $348.60, the gap reflects how strongly expectations lean on future media and fan monetization.

The upcoming ramp-up in high-value national media rights fees for the NBA (beginning in fiscal '26) will offset the recent step-down in local media rights, positioning MSG Sports for an overall increase in recurring media revenue and supporting both revenue growth and higher net margins over the next several years.

Want to see what backs that kind of earnings power story? The narrative focuses on revenue resilience, margin expansion, and a future earnings multiple that is anything but modest.

Result: Fair Value of $348.60 (OVERVALUED)

However, those assumptions can quickly look stretched if local media fees weaken further or if the performance of the Knicks and Rangers cools fan demand and related revenue streams.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Next Steps

If this mix of excitement and concern around MSGS leaves you unsure, it is worth acting now to review the 1 key reward and 1 important warning sign.

Looking for more investment ideas?

If MSGS has your attention, do not stop here. Use the Simply Wall Street Screener to spot other stocks that could sharpen and diversify your watchlist.

• Target reliable cash generators by scanning companies with healthy payout potential and resilient income streams through the 9 dividend fortresses.
• Hunt for quality at a measured price by reviewing stocks that pair attractive fundamentals with room for market recognition via the 47 high quality undervalued stocks.
• Prioritise resilience by filtering for companies that score well on financial strength and stability inside the 63 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.